In 2024, the mortality rate for genitourinary system diseases in Canada is forecasted to be 6.37 thousand deaths, representing an increase from 2023. By 2028, this is expected to reach 6.69 thousand deaths. The annual year-on-year growth exhibits a consistent upward trend with a CAGR of approximately 1% over the five-year forecast period from 2024 to 2028. This steady increase indicates an anticipated rise in mortality rates for these diseases.

Future trends to watch for:

Advancements in medical technology and healthcare practices could potentially mitigate the mortality increment.
Public health policies focusing on prevention and early diagnosis might curb the expected rise.
Demographic changes, such as an aging population, could further influence the mortality trends of genitourinary system diseases.